EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Role of Microenvironment in Bispecific Antibodies Treatment in Multiple Myeloma

Serena Barachini, Raffaella Cassano Cassano, Francesca Ronca, Iacopo Petrini, Sara Galimberti, Gabriele Buda

European Journal of Haematology · 2026

DOI: 10.1111/ejh.70168 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Haematology, 2026. Verfasst von Serena Barachini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Multiple Myeloma, Tumor Microenvironment, Antineoplastic Agents, Immunological. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 123 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is a clonal plasma cell malignancy that remains largely incurable despite major therapeutic advances. T‐cell‐redirecting bispecific antibodies (BsAbs) and chimeric antigen receptor T (CAR‐T) cells have recently emerged as highly effective therapies in relapsed/refractory MM, inducing deep responses even in heavily pretreated patients. However, disease relapse, limited durability of response, and treatment‐related toxicities remain frequent, underscoring the need to better understand mechanisms of resistance. Accumulating evidence indicates that the tumor microenvironment (TME) plays a central role in shaping BsAb efficacy in MM. Immunosuppressive cellular components, including regulatory T‐cells, myeloid‐derived suppressor cells, and dysfunctional antigen‐presenting cells, as well as inhibitory cytokines, hypoxia, and metabolic constraints within the TME, profoundly impair T‐cell activation, expansion, and persistence following BsAb engagement. In addition, chronic CD3 stimulation within the TME may promote T‐cell exhaustion, contributing to suboptimal responses and disease progression. This review focuses on the dynamic interplay between BsAbs and the MM TME, highlighting how microenvironment‐driven immune suppression, antigen escape, and impaired T‐cell fitness influence clinical outcomes. We further discuss emerging strategies designed to overcome these barriers, including rational combination approaches, immunomodulatory agents, and next‐generation trispecific antibodies that enhance co‐stimulation or dual‐antigen targeting. Understanding and therapeutically modulating the TME represents a critical step toward improving the depth, durability, and safety of BsAb‐based therapies in MM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, BispecificMultiple MyelomaTumor MicroenvironmentAntineoplastic Agents, ImmunologicalHumansT-LymphocytesAnimalsTreatment Outcome

Stichwörter der Autor:innen

bispecific antibodiesdrug resistancemultiple myelomatumor microenvironment

Substanzen

Antibodies, BispecificAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
  • University of Washington, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
  • Department of Translational Research and New Technologies in Surgery and Medicine, University of Pisa, Pisa, Italy.
  • Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy.

Zitieren

APA

Barachini, S., Cassano Cassano, R., Ronca, F., Petrini, I., Galimberti, S., & Buda, G. (2026). The Role of Microenvironment in Bispecific Antibodies Treatment in Multiple Myeloma. European Journal of Haematology. https://doi.org/10.1111/ejh.70168

Vancouver

Barachini S, Cassano Cassano R, Ronca F, Petrini I, Galimberti S, Buda G. The Role of Microenvironment in Bispecific Antibodies Treatment in Multiple Myeloma. European Journal of Haematology. 2026. doi:10.1111/ejh.70168

BibTeX
@article{Barachini2026,
  author = {Barachini, Serena and Cassano Cassano, Raffaella and Ronca, Francesca and Petrini, Iacopo and Galimberti, Sara and Buda, Gabriele},
  title = {The Role of Microenvironment in Bispecific Antibodies Treatment in Multiple Myeloma},
  journal = {European Journal of Haematology},
  year = {2026},
  doi = {10.1111/ejh.70168}
}
Kostenlos starten →